Browse > Article
http://dx.doi.org/10.18204/JISSiS.2016.3.2.064

Development of Dual-Arm Anticancer Drug Compounding Robot and Preparation System with Adaptability and High-Speed  

Nam, Giyoon (Biomedical Engineering Branch, National Cancer Center)
Kim, Young Joo (Dept. Pharmacy, National Cancer Center)
Kim, Yun Jung (Biomedical Engineering Branch, National Cancer Center)
Kim, Yeoun Jae (Biomedical Engineering Branch, National Cancer Center)
Seo, Jung Ae (Dept. Pharmacy, National Cancer Center)
Kim, Kyunghwan (NT Robot, Co.)
Kim, Kwang Gi (Biomedical Engineering Branch, National Cancer Center)
Publication Information
Journal of International Society for Simulation Surgery / v.3, no.2, 2016 , pp. 64-68 More about this Journal
Abstract
Aim Robots are able to increase safety for pharmacy staff as separating from toxicity of anti-cancer drugs. For patient safety, it would provide right dose of the drugs. Additionally, it can reduce price of the drugs. Therefore, in this study, a novel compounding anticancer drugs robot system (Dupalro) was developed. Methods We used the robot system, Motoman dual-arm robot from YASKAWA, Japan and medications which are adapted for the robot were constructed. In order to develop a process of compounding anticancer drugs, information about five medications that are required to make anticancer drugs in hospitals was used. Results System for the five types of medications was constructed, and relating procedures for anticancer drugs compounding robot were developed. Conclusion Dupalro successfully was able to not only provide incremental safety and efficiency for both patients and pharmacy staff, but also decrease price of anticancer drugs.
Keywords
Dupalro; Medication; Anticancer drugs; Safety; Automatic robot; Compounding; Pharmacists;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Yoshida J, Tei G, Mochizuki C, Masu Y, Koda S, Kumagai S. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. The Annals of occupational hygiene 2009;53:153-160
2 Connor TH, McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in health care settings. CA: a cancer journal for clinicians 2006;56:354-365   DOI
3 Power LA. Hazardous drugs as compounded sterile preparations. Compounding Sterile Preparations 2009:79
4 Nurgat Z, Faris D, Mominah M, Vibar A, Al-Jazairi A, Ewing S et al. A three-year study of a first-generation chemotherapy-compounding robot. American Journal of Health-System Pharmacy 2015;72:1036-1045   DOI
5 National cancer center. In. National Cancer Center, 2016
6 Howard DH, Bach PB, Berndt ER, Conti RM. Pricing in the market for anticancer drugs. Journal of Economic Perspectives 2015;29: 139-162   DOI
7 Schrag D, Hanger M. Medical oncologists' views on communicating with patients about chemotherapy costs: A pilot survey. Journal of Clinical Oncology 2007;25:233-237   DOI
8 Tong WH, van der Sluis IM, Alleman C, van Litsenburg RR, Kaspers G, Pieters R et al. Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: The impact of expensive chemotherapy. haematologica 2013:haematol. 2012.073510
9 Martin S, Beach L. The adverse health effects of occupational exposure to hazardous drugs. Community Oncology 2005;2:397-400   DOI
10 Seger A, Churchill W, Keohane C. Impact of robotic antineoplastic preparation on safety, workflow, and costs. J Oncol Pract 2012;8(6): 344-349. Doi: 10.1200.JOP 2012;1   DOI
11 Kriheli M, Eric S-T, Daskal G. Robotic system for compounding medication. In: Google Patents, 2014
12 Rich D, Fricker Jr M, Cohen M, Levine S. Guidelines for the safe preparation of sterile compounds: Results of the ismp sterile preparation compounding safety summit of october 2011. Hospital Pharmacy 2013;48:282-294   DOI
13 Bar-Shalom D. The challenge of automated compounding. InPediatric formulations: Springer, 2014:181-191.